col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


41 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Diabetes Therapy
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Apr―20 Effects of Two COVID-19 Lockdowns on HbA1c Levels in Patients with Type 1 Diabetes and Associations with Digital Treatment, Health Literacy, and Diabetes Self-Management: A Multicenter, Observational Cohort Study Over 3 Years Daniel Tajdar, Dagmar Lühmann, Laura Walther, Lasse Bittner, Martin Scherer, Ingmar Schäfer
2 [GO] 2024―Mrz―27 Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity Klara R. Klein, Trine J. Abrahamsen, Anna R. Kahkoska, G. Caleb Alexander, Christopher G. Chute, Melissa Haendel, et al. (+6)
3 [GO] 2023―Nov―17 Telehealth Use and Healthcare Utilization Among Individuals with Type 2 Diabetes During the COVID-19 Pandemic: Evidence From Louisiana Medicaid Claims Yixue Shao, Lizheng Shi, Elizabeth Nauman, Eboni Price-Haywood, Charles Stoecker
4 [GO] 2023―Nov―15 Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, et al. (+24)
5 [GO] 2023―Okt―06 Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy Vincenzo M. Monda, Claudio Voci, Felice Strollo, Angelina Passaro, Salvatore Greco, Marcello Monesi, et al. (+5)
6 [GO] 2023―Okt―05 Correction to: Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England Adrian H. Heald, David A. Jenkins, Richard Williams, Rajshekhar N. Mudaliar, Amber Khan, Akheel Syed, et al. (+6)
7 [GO] 2023―Sep―26 New-Onset Diabetes Mellitus in COVID-19: A Scoping Review Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, et al. (+24)
8 [GO] 2023―Aug―25 Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England Adrian H. Heald, David A. Jenkins, Richard Williams, Rajshekhar N. Mudaliar, Amber Khan, Akheel Syed, et al. (+6)
9 [GO] 2023―Feb―22 The Effect of the COVID-19 Pandemic on HbA1c Testing: Prioritization of High-Risk Cases and Impact of Social Deprivation David Holland, Adrian H. Heald, Fahmy F. W. Hanna, Mike Stedman, Pensée Wu, Julius Sim, et al. (+13)
10 [GO] 2022―Dez―27 Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study Alexandra A. Matias, Inês Manique, Teresa Sabino, Teresa Rego, Claudia Mihon, António Panarra, et al. (+2)
11 [GO] 2022―Dez―07 COVID-19 Vaccination and Diabetes Mellitus: How Much Has It Made a Difference to Outcomes Following Confirmed COVID-19 Infection? Adrian H. Heald, David A. Jenkins, Richard Williams, Rajshekhar N. Mudaliar, Asma Naseem, Kelly A. Bowden Davies, et al. (+3)
12 [GO] 2022―Nov―29 Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic Harshpreet Swaich, Andrew Advani
13 [GO] 2022―Nov―27 Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study Rongdong Huang, Xiaoqin Liu, Fangqin Xie, Junrong Li, Zhangbin Tang, Yuying Wu, et al. (+2)
14 [GO] 2022―Sep―22 Diabetes Mellitus May Exacerbate Liver Injury in Patients with COVID-19: A Single-Center, Observational, Retrospective Study Mutsuko Minata, Kouji H. Harada, Tomoyuki Yamaguchi, Tomoko Fujitani, Hidemitsu Nakagawa
15 [GO] 2022―Aug―27 The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact Nitin Kapoor, Sanjay Kalra, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, Maciej Banach, et al. (+19)
16 [GO] 2022―Apr―13 Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors Adrian H. Heald, David A. Jenkins, Richard Williams, Matthew Sperrin, Rajshekhar N. Mudaliar, Akheel Syed, et al. (+8)
17 [GO] 2022―Mrz―25 The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis Adrian H. Heald, David A. Jenkins, Richard Williams, Matthew Sperrin, Helene Fachim, Rajshekhar N. Mudaliar, et al. (+8)
18 [GO] 2022―Jan―30 Retrospective Study on the Effects of Glucose Abnormality on COVID-19 Outcomes in Japan Yuya Nishida, Tomoya Mita, Makoto Hiki, Yasushi Matsushita, Toshio Naito, Hirotaka Watada
19 [GO] 2021―Okt―26 Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review Djordje S. Popovic, Nikolaos Papanas, Anca Pantea Stoian, Ali A. Rizvi, Andrej Janez, Manfredi Rizzo
20 [GO] 2021―Okt―06 Impact of SARS-CoV-2 on Progression of Glycemic and Cardiometabolic Variables and Changes in Insulin Indices: A Longitudinal Study Alpesh Goyal, Yashdeep Gupta, Mani Kalaivani, Neerja Bhatla, Nikhil Tandon
21 [GO] 2021―Sep―24 Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study Rifat Emral, Cem Haymana, Ibrahim Demirci, Ilker Tasci, Mustafa Sahin, Erman Cakal, et al. (+13)
22 [GO] 2021―Aug―16 Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study Rifat Emral, Cem Haymana, Ibrahim Demirci, Ilker Tasci, Mustafa Sahin, Erman Cakal, et al. (+13)
23 [GO] 2021―Aug―14 The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond Pratik Choudhary, Virginia Bellido, Matthijs Graner, Bernd Altpeter, Americo Cicchetti, Isabelle Durand-Zaleski, Finn Børlum Kristensen
24 [GO] 2021―Aug―02 Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future Thomas Danne, Catarina Limbert, Manel Puig Domingo, Stefano Del Prato, Eric Renard, Pratik Choudhary, Alexander Seibold
25 [GO] 2021―Jul―18 Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States Kristina S. Boye, Elif Tokar Erdemir, Nathan Zimmerman, Abraham Reddy, Brian D. Benneyworth, Matan C. Dabora, et al. (+8)
26 [GO] 2021―Jul―09 The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study Lisa Ludwig, Nicolas Scheyer, Thomas Remen, Bruno Guerci
27 [GO] 2021―Mrz―17 Diabetic Ketoacidosis at Emergency Department Presentation During the First Months of the SARS-CoV-2 Pandemic in Israel: A Multicenter Cross-Sectional Study Ron Jacob, Giora Weiser, Danna Krupik, Dania Takagi, Shuny Peled, Naama Pines, et al. (+8)
28 [GO] 2020―Dez―26 New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry Stella Papachristou, Iliana Stamatiou, Anca P. Stoian, Nikolaos Papanas
29 [GO] 2020―Dez―12 Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel Manoj Chawla, Sunil M. Jain, Jothydev Kesavadev, Brij M. Makkar, Vijay Viswanathan, Mangesh Tiwaskar, et al. (+8)
30 [GO] 2020―Dez―05 Inpatient Hyperglycemia Management and COVID-19 Virginia Bellido, Antonio Pérez
31 [GO] 2020―Okt―14 A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions Antonio C. Bossi, Franco Forloni, Paolo L. Colombelli
32 [GO] 2020―Okt―14 Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions Dimitrios Patoulias, Christodoulos Papadopoulos, Alexandra Katsimardou, Maria Toumpourleka, Michael Doumas
33 [GO] 2020―Sep―03 COVID-19, Diabetes and Ramadan Tahseen A. Chowdhury, Salman Waqar, Sufyan Hussain, Syed H. Ahmed, Ateeq Syed, Ali Karamat, et al. (+2)
34 [GO] 2020―Aug―04 ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role? Vincenzo M. Monda, Francesca Porcellati, Felice Strollo, Sandro Gentile
35 [GO] 2020―Jul―18 Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach Bhawna Attri, Alpesh Goyal, Yashdeep Gupta, Nikhil Tandon
36 [GO] 2020―Jul―13 Diabetes and Novel Coronavirus Infection: Implications for Treatment David M. Williams, Asif Nawaz, Marc Evans
37 [GO] 2020―Jun―06 COVID-19: Impact of and on Diabetes Jonathan Schofield, Lalantha Leelarathna, Hood Thabit
38 [GO] 2020―Mai―23 Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends Antonio Carlo Bossi, Franco Forloni, Paolo Luigi Colombelli
39 [GO] 2020―Mai―11 Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy Benedetta Maria Bonora, Federico Boscari, Angelo Avogaro, Daniela Bruttomesso, Gian Paolo Fadini
40 [GO] 2020―Mai―07 COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone? Theano Penlioglou, Stella Papachristou, Nikolaos Papanas
41 [GO] 2020―Apr―29 The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak Sandro Gentile, Felice Strollo, Antonio Ceriello
 [1] 

41 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.016 sec